CAR-based therapies: opportunities for immuno-medicine beyond cancer

H Aghajanian, JG Rurik, JA Epstein - Nature metabolism, 2022 - nature.com
One of the most exciting new therapies for cancer involves the use of autologous T cells that
are engineered to recognize and destroy cancerous cells. Patients with previously …

Macrophage–stroma interactions in fibrosis: biochemical, biophysical, and cellular perspectives

GF Vasse, M Nizamoglu, IH Heijink… - The Journal of …, 2021 - Wiley Online Library
Fibrosis results from aberrant wound healing and is characterized by an accumulation of
extracellular matrix, impairing the function of an affected organ. Increased deposition of …

[HTML][HTML] Fibroblast activation protein activates macrophages and promotes parenchymal liver inflammation and fibrosis

AT Yang, YO Kim, XZ Yan, H Abe, M Aslam… - Cellular and Molecular …, 2023 - Elsevier
Background & Aims Fibroblast activation protein (FAP) is expressed on activated fibroblast.
Its role in fibrosis and desmoplasia is controversial, and data on pharmacological FAP …

The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDG

L Lan, H Liu, Y Wang, J Deng, D Peng, Y Feng… - European journal of …, 2022 - Springer
Purpose This study aimed to compare the detection performance of [68 Ga] Ga-DOTA-FAPI-
04 and [18F] FDG PET/CT in the patients with various oncological and non-oncological …

Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases

P Yang, Q Luo, X Wang, Q Fang, Z Fu, J Li… - American Journal of …, 2023 - atsjournals.org
Rationale: Sustained activation of lung fibroblasts and the resulting oversynthesis of the
extracellular matrix are detrimental events for patients with interstitial lung diseases (ILDs) …

Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by miR-29c and miR-129 intercellular transfer

B Nataliya, A Mikhail, P Vladimir, G Olga… - … & Molecular Medicine, 2023 - nature.com
To date, pulmonary fibrosis remains an unmet medical need. In this study, we evaluated the
potency of mesenchymal stromal cell (MSC) secretome components to prevent pulmonary …

[HTML][HTML] Diagnostic and therapeutic potential of protease inhibition

N Ćwilichowska, KW Świderska, A Dobrzyń… - Molecular Aspects of …, 2022 - Elsevier
Proteases are enzymes that hydrolyze peptide bonds in proteins and peptides; thus, they
control virtually all biological processes. Our understanding of protease function has …

Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells?

N Basalova, N Alexandrushkina, O Grigorieva… - Biomolecules, 2023 - mdpi.com
The development of tissue fibrosis is a complex process involving the interaction of multiple
cell types, which makes the search for antifibrotic agents rather challenging. So far …

A vaccine against fibroblast activation protein improves murine cardiac fibrosis by preventing the accumulation of myofibroblasts

S Yoshida, H Hayashi, T Kawahara, S Katsuki… - Circulation …, 2025 - ahajournals.org
BACKGROUND: Myofibroblasts are primary cells involved in chronic response-induced
cardiac fibrosis. Fibroblast activation protein (FAP) is a relatively specific marker of activated …

Intercellular interaction between FAP+ fibroblasts and CD150+ inflammatory monocytes mediates fibrostenosis in Crohn's disease

BJ Ke, S Abdurahiman, F Biscu, G Zanella… - The Journal of Clinical …, 2024 - jci.org
Crohn's disease (CD) is marked by recurring intestinal inflammation and tissue injury, often
resulting in fibrostenosis and bowel obstruction, necessitating surgical intervention with high …